Empresa Iovance Biotherapeutics, Inc.
Acciones
IOVA
US4622601007
Biotecnología e investigación médica
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
11,92 USD | +1,23 % | +1,75 % | +46,56 % |
Resumen de negocios
Número de empleados: 557
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Autologous Tumor Infiltrating Lymphocytes
100,0
%
| 0 | nan % | 1 | 100,0 % | - |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 1 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frederick Vogt
CEO | Chief Executive Officer | 50 | 30/09/16 |
Director of Finance/CFO | 51 | 14/12/20 | |
Brian Shew
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/21 |
Chief Tech/Sci/R&D Officer | 51 | 18/07/19 | |
Igor Bilinsky
COO | Chief Operating Officer | 51 | 15/03/21 |
Merrill McPeak
BRD | Director/Board Member | 88 | 20/07/11 |
Sara Pellegrino
IRC | Investor Relations Contact | - | - |
Tracy Winton
HRO | Human Resources Officer | - | 01/04/20 |
Raj K. Puri
PRN | Corporate Officer/Principal | - | 01/03/22 |
Jim Ziegler
PRN | Corporate Officer/Principal | - | 01/02/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Merrill McPeak
BRD | Director/Board Member | 88 | 20/07/11 |
Director/Board Member | 56 | 07/06/16 | |
Michael Weiser
BRD | Director/Board Member | 61 | 15/03/18 |
Wendy Yarno
BRD | Director/Board Member | 68 | 18/04/23 |
Ryan Maynard
BRD | Director/Board Member | 54 | 16/02/15 |
Iain Dukes
CHM | Chairman | 65 | 01/06/16 |
Director/Board Member | 52 | 10/06/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 2 842 158 | 0 | 0 | 92,70 % |
Acción B | 0 | 194 | 0 | 0 | |
Acción C | 1 | 278 847 679 | 258 503 652 ( 92,70 %) | 0 |
Información de la empresa
Iovance Biotherapeutics, Inc.
825 Industrial Road Suite 400
94070, San Carlos
+650 260 7120
http://www.iovance.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+46,56 % | 3296,42 M | |
-20,68 % | 10,91 mil M | |
-33,68 % | 2193,93 M | |
-14,31 % | 2156,1 M | |
-28,50 % | 1496,08 M | |
+28,47 % | 1087,77 M | |
-3,28 % | 737 M | |
-24,07 % | 404 M | |
-46,33 % | 386 M | |
+17,30 % | 342 M |
- Bolsa de valores
- Acciones
- Acción IOVA
- Empresa Iovance Biotherapeutics, Inc.